coronary reperfusion procoagulant response plasminogen activator von Willebrand factor acute myocardial infarction effects early coronary recanalization plasma levels procoagulant acute phase proteins fastacting plasminogen activator inhibitor von Willebrand factor patients myocardial infarction intravenous recombinant tissue-type plasminogen activator rt-PA onset symptoms Coronary angiography min start rt-PA infusion Continuous electrocardiographic recordings plasma creatine kinase MB isoenzyme CK MB first Plasma plasminogen activator inhibitor activity Willebrand factor C-reactive protein rt-PA infusion first days days entire group plasminogen activator inhibitor activity day significant increase values times von Willebrand factor first days infarction days C-reactive protein day eightfold increase values admission patients patent infarct-related artery min infarct size integrated CK MB time ST segment elevation half-maximum peak C-reactive protein values patients occluded artery min patients early recanalization plasminogen activator inhibitor activity day day von Willebrand factor early coronary recanalization response plasminogen activator inhibitor activity von Willebrand factor myocardial infarction likely extent ischemia necrosis consequent acute phase reaction early postinfarction procoagulant state prompt recanalization risk thromboembolic complications first days myocardial infarction 